ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Strict System For Protection Of Human Subjects Ordered In Wake Of NIH Investigation

August 9, 1991

NIH Revises Application Receipt Dates

November 22, 1985

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report

July 10, 1998

DCE Advisors OK RFAs In Occupational Cancer, H. Pylori

April 1, 1994